Sublingual immunotherapy | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,052 results for “Sublingual immunotherapy”

Trials

View all 4068 →

Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy

64 participants · First posted Mar 24, 2021

Not yet recruiting

UNC Cashew Sublingual Immunotherapy

45 participants · First posted Sep 12, 2025

Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies

31 participants · First posted Feb 8, 2012

Drugs

View all 218 →

Latex allergy sublingual immunotherapy (ALK-Albello)

Ragweed pollen allergen sublingual immunotherapy(Stallergenes Greer Ltd.)

Latex allergy sublingual immunotherapy(ALK-Abello A/S)

Organizations

View all 25 →

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

United States

Janssen Alzheimer Immunotherapy Research & Development LLC

United States

PETER MACCALLUM CANCER INSTITUTE

Australia

News

View all 3741 →

Children's Hospital Colorado Launches Sublingual Immunotherapy Program for Pediatric Food Allergies

Sublingual Immunotherapy Faces Hurdles in Gaining Full FDA Approval

Stallergenes Greer Transitions Actair® Promotional Activities from Shionogi to CEOLIA in Japan

Page 1 of 806